<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=5442258&amp;fmt=gif">
Skip to content

Accelerating drug development and manufacturing

GL CHEMTEC is your trusted CDMO partner for API development and tailored polymers for drug delivery. 

Custom solutions for APIs and biomedical materials

SmallMoleculeIcon (002)
Small Molecule API Development

Synthetic route development and optimization, early-process scale-up of API targets and RSMs.

LEARN MORE >

polymer
Tailored Biomedical Polymers

Novel biomedical polymers and hydrogels to enhance drug delivery and medical device applications. 

LEARN MORE >

integration
Integrated Solutions

Full-spectrum solutions combining small molecule API development and tailored polymers for delivery.

LEARN MORE >

Test tubes

Why GL CHEMTEC?

As an independent, founder-led life sciences company, GL CHEMTEC is passionate about your success and committed to solving your most complex chemistry challenges. We are fast and flexible, and our collaborative partnership approach means that we scale and adapt according to your needs.

Molecule-1
A next-level API partner  

offering a unique combination of small molecule and polymer expertise.

check
Tackle complex chemistry challenges

with our deep expertise in small molecule chemistry and tailored polymers, and a collaborative approach.

LeafIcon
Drive innovation with a green chemistry mindset

committed to sustainability and green chemistry best practices. 

IntegratedSolutionsIcon (002)
Accelerate early-stage API development and innovative drug delivery solutions 

with seamless continuity from R&D to manufacturing.

NorthAmericaicon
North American location and security of supply  

offering an alternative to traditional supply chains and overseas partners.

people
Highly customer-centric culture   

reflected by our 22 years of success in life sciences, delivering innovative solutions with unrivalled speed, agility, and passion.

About GL CHEMTEC

Established in 2002, GL CHEMTEC is a leading, independent CRO/CDMO partner. We provide innovative solutions and technologies to various industries, including pharmaceutical, biotech, medical device/biomedical materials, ophthalmology, and tailored polymers. Our comprehensive services cover almost all areas of the drug development process, from discovery to manufacturing, utilizing our state-of-the-art facilities in North America.

At GL CHEMTEC, green chemistry is more than a service, it is a core value that shapes our approaches, processes, and operations. We are proud of our enduring partnerships with top-tier life science establishments worldwide, constantly striving for excellence in areas such as small molecule R&D, process development, scale-up, green chemistry, and drug delivery.

Customers often approach us with their most important chemistry challenges, and we excel in solving them. With our expertise in small molecule API development and tailored polymers, we offer fast, flexible, and world-class solutions. We encourage you to explore our capabilities, facilities, and to reach out to us for more information. Together, we can accelerate the development of next-generation therapeutics and biomedical materials, ultimately improving the human condition.

Recent blogs

Awards

Bell Mid-Sized Business of the Year
2017 

Canadian Business Review Board Best Business Award
2021, 2022, 2023, 2024, 2025

Winner Magazine - Outstanding Canadian Business
2023

Outstanding Business in Customer Satisfaction, Business Leadership, Outstanding Service, Strong Vision

2025 CBRB (1)
2025 Best Chemical Industry in Oakville (1)
2025 CBRB
(RISIZED) 2024 CBRB 2
(RESIZED) 2023 CBRB
(RISIZED) 2023 WINNER MAGAZINE
(RISIZED) 2022 CBRB 1
(RESIZED) 2021 CBRB

ISO Certifications

ISO 13485:2016 – Medical Device & Early Clinical Study Support

ISO 9001:2015 – A Commitment to Quality and Traceability

 

ISO 13485:2016 – Medical Device & Early Clinical Study Support
ISO 9001:2015 – A Commitment to Quality and Traceability

CCD Partners Pre-Clinical CRO Watchlist

GL CHEMTEC is proud to be highlighted as a top potential disruptor in the pre-clinical CRO space due to exciting recent corporate developments and our potential to impact the industry in the near future.

The Watchlist includes 112 independent players in the pre-clinical CRO space, each of which has the potential to disrupt the established market in the next few years.